CorTec gets second FDA breakthrough designation
Brain Interchange is now designated for both stroke motor rehab and communication in quadriplegia.
30 events
Brain Interchange is now designated for both stroke motor rehab and communication in quadriplegia.
Its fully implanted wireless BCI system joins the NMPA special review procedure for innovative devices.
Science begins selling PRIMA in Europe for geographic atrophy caused by macular degeneration.
The first participant in the FDA-approved speech restoration study was implanted at University of Michigan Health.
Motif's wireless DOT implant gets approval for an early feasibility study in treatment-resistant depression.
Two years after its first implant, Neuralink says 21 people have received its device.
New research lab aims at non-invasive, high-bandwidth BCIs using molecules and ultrasound.
Layer 7 will be integrated with Medtronic's StealthStation surgical navigation system.
Paradromics receives IDE approval for a speech restoration study with a fully implantable BCI.
Member states adopt the Recommendation on the Ethics of Neurotechnology in Samarkand.
The subretinal implant restored functional central vision in patients with geographic atrophy.
A Nature Biomedical Engineering study describes decoding and stimulation with surface arrays in patients.
Stanford team shows imagined speech can be decoded and proposes safeguards against unintended decoding.
Neuralink opens its trial at two sites in Great Britain.
A surface EMG wristband decodes gestures and handwriting across people without per-user calibration.
UC Davis implant turns attempted speech of a man with ALS into synthesized voice with very low delay.
At University of Michigan Health the device was implanted, recorded brain signals and was removed in under 20 minutes.
Apple announces Switch Control support for brain-computer interfaces as a new input protocol.
The FDA grants breakthrough status to Neuralink's device for people with severe speech impairment.
The cortical electrode array is cleared for implantation of up to 30 days for recording and stimulation.
UCSF and UC Berkeley decode speech attempts into audible voice in near real time.
A feasibility trial extends N1 implant control to an investigational assistive robotic arm.
Neuralink gets approval for its first study outside the United States.
Science reports preliminary positive results for vision restoration in the PRIMAvera pivotal trial.
Synchron announces positive results from its early feasibility study of the endovascular Stentrode.
The FDA grants breakthrough device status to Neuralink's visual prosthesis for people with vision loss.
UC Davis implant decodes attempted speech of a man with ALS into text with high accuracy after short calibration.
UCSF team decodes a stroke survivor's attempted speech in two languages from shared cortical representations.
Science takes over the PRIMA retinal prosthesis and its ongoing clinical trials from Pixium Vision.
Neuralink says it conducted its first human implantation in January and shares a progress snapshot.